» Articles » PMID: 35456428

Association of Androgenic Regulation and MicroRNAs in Acinar Adenocarcinoma of Prostate

Abstract

Background: Prostate cancer represents 3.8% of cancer deaths worldwide. For most prostate cancer cells to grow, androgens need to bind to a cellular protein called the androgen receptor (AR). This study aims to demonstrate the expression of five microRNAs (miRs) and its influence on the AR formation in patients from the northern region of Brazil.

Material And Methods: Eighty-four tissue samples were investigated, including nodular prostatic hyperplasia (NPH) and acinar prostatic adenocarcinoma (CaP). Five miRs (27a-3p, 124, 130a, 488-3p, and 506) were quantified using the TaqMan Real Time PCR method and AR was measured using Western blotting.

Results: Levels of miRs 124, 130a, 488-3p, and 506 were higher in NPH samples. Conversely, in the CaP cases, higher levels of miR 27a-3p and AR were observed.

Conclusion: In the future, these microRNAs may be tested as markers of CaP at the serum level. The relative expression of AR was 20% higher in patients with prostate cancer, which suggests its potential as a biomarker for prostate malignancy.

Citing Articles

Assessing the Mechanism of Action of "Fructus Ligustri Lucidi-Cuscutae Semen" in Prostate Cancer Treatment Using Network Pharmacology and Molecular Docking.

Lu D, Shang J, Guo X, Zhang Y Comput Math Methods Med. 2022; 2022:7543619.

PMID: 36330452 PMC: 9626213. DOI: 10.1155/2022/7543619.

References
1.
Fletcher C, Sulpice E, Combe S, Shibakawa A, Leach D, Hamilton M . Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer. Oncogene. 2019; 38(28):5700-5724. PMC: 6755970. DOI: 10.1038/s41388-019-0823-5. View

2.
Ramalho-Carvalho J, Martins J, Cekaite L, Sveen A, Torres-Ferreira J, Graca I . Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1. Cancer Lett. 2016; 385:150-159. DOI: 10.1016/j.canlet.2016.10.028. View

3.
Zhang T, Karsh L, Nissenblatt M, Canfield S . Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer. Clin Genitourin Cancer. 2019; 18(1):1-10. DOI: 10.1016/j.clgc.2019.09.015. View

4.
Balacescu O, Dumitrescu R, Marian C . MicroRNAs Role in Prostate Cancer. Methods Mol Biol. 2018; 1856:103-117. DOI: 10.1007/978-1-4939-8751-1_6. View

5.
Boll K, Reiche K, Kasack K, Morbt N, Kretzschmar A, Tomm J . MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene. 2012; 32(3):277-85. DOI: 10.1038/onc.2012.55. View